Описание
This application is available in English, French, Spanish, Portuguese, and Russian. The language of the app will be determined by the language setting of the user’s smartphone.
Based on international guidelines published in 2022, which were developed with methodological support from the Institut National du Cancer (INCa) in France and endorsed by the International Society on Thrombosis and Hemostasis (ISTH), this app is a practical step-by-step guide for the prophylaxis and treatment of venous thromboembolism (VTE: deep vein thrombosis (DVT), pulmonary embolism (PE), catheter-related thrombosis) in patients with cancer, including:
• Prophylaxis in hospitalized and ambulatory patients
• Recommendations for the treatment of both non-catheter and catheter-related VTE
• Specific recommendations related to special cancer situations
• Recommendations for initial, short-term, and long-term treatment
This treatment algorithm for anticoagulant use (low molecular weight heparins (LMWH), direct oral anticoagulants (DOAC), and vitamin K antagonists (VKA)) is intended for physicians and other healthcare professionals treating patients with cancer. It should not replace clinical judgement. It is based on clinical practice guidelines published in 2022:
Farge D*, Frere C*, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-García LA, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2022 Jul;23(7):e334-e347.
While these guidelines rely on the best available evidence at the time of publication, the clinician is advised to use clinical judgement when making decisions about prophylaxis and treatment of cancer-associated thrombosis (CAT).
APP AUTHORS / STEERING COMMITTEE
Professor Dominique Farge (France) (Co-Chair)
Professor James Douketis (Canada) (Co-Chair)
Dr Syed Abutalib (United States)
Professor Cihan Ay (Austria)
Dr Darko Antic (Serbia)
Professor Henri Bounameaux (Switzerland)
Professor Benjamin Brenner (Israel)
Dr Dialina Brilhante (Portugal)
Dr Patricis Casais (Argentina)
Dr Jean M. Connors (United States)
Professor Corinne Frere (France)
Professor Maria Cecilia Guillermo Esposito (Uruguay)
Professor Takayuki Ikezoe (Japan)
Professor Alok A. Khorana (United States)
Right Honourable Professor Lord Ajay Kakkar (United Kingdom)
Professor Luis Meillon-Garcia (Mexico)
Professor Andres Munoz-Martin (Spain)
Professor Ingrid Pabinger (Austria)
Dr Pedro Henrique Prata (Brazil)
ABOUT ITAC-CME
The International Initiative on Thrombosis and Cancer (ITAC-CME) is the international section of the Groupe Francophone Thrombose et Cancer (GFTC). A multidisciplinary group, the members of ITAC-CME are clinicians and researchers from across the globe, led by a core group of GFTC members. Through education of physicians, nurses, and allied health professionals, ITAC-CME is committed to disseminating relevant and peer-reviewed prophylaxis and treatment guidelines for VTE in cancer that will help to reduce a substantial economic burden on health care systems and improve the lives of millions of patients worldwide.
Hide
Показать больше...
Based on international guidelines published in 2022, which were developed with methodological support from the Institut National du Cancer (INCa) in France and endorsed by the International Society on Thrombosis and Hemostasis (ISTH), this app is a practical step-by-step guide for the prophylaxis and treatment of venous thromboembolism (VTE: deep vein thrombosis (DVT), pulmonary embolism (PE), catheter-related thrombosis) in patients with cancer, including:
• Prophylaxis in hospitalized and ambulatory patients
• Recommendations for the treatment of both non-catheter and catheter-related VTE
• Specific recommendations related to special cancer situations
• Recommendations for initial, short-term, and long-term treatment
This treatment algorithm for anticoagulant use (low molecular weight heparins (LMWH), direct oral anticoagulants (DOAC), and vitamin K antagonists (VKA)) is intended for physicians and other healthcare professionals treating patients with cancer. It should not replace clinical judgement. It is based on clinical practice guidelines published in 2022:
Farge D*, Frere C*, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-García LA, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2022 Jul;23(7):e334-e347.
While these guidelines rely on the best available evidence at the time of publication, the clinician is advised to use clinical judgement when making decisions about prophylaxis and treatment of cancer-associated thrombosis (CAT).
APP AUTHORS / STEERING COMMITTEE
Professor Dominique Farge (France) (Co-Chair)
Professor James Douketis (Canada) (Co-Chair)
Dr Syed Abutalib (United States)
Professor Cihan Ay (Austria)
Dr Darko Antic (Serbia)
Professor Henri Bounameaux (Switzerland)
Professor Benjamin Brenner (Israel)
Dr Dialina Brilhante (Portugal)
Dr Patricis Casais (Argentina)
Dr Jean M. Connors (United States)
Professor Corinne Frere (France)
Professor Maria Cecilia Guillermo Esposito (Uruguay)
Professor Takayuki Ikezoe (Japan)
Professor Alok A. Khorana (United States)
Right Honourable Professor Lord Ajay Kakkar (United Kingdom)
Professor Luis Meillon-Garcia (Mexico)
Professor Andres Munoz-Martin (Spain)
Professor Ingrid Pabinger (Austria)
Dr Pedro Henrique Prata (Brazil)
ABOUT ITAC-CME
The International Initiative on Thrombosis and Cancer (ITAC-CME) is the international section of the Groupe Francophone Thrombose et Cancer (GFTC). A multidisciplinary group, the members of ITAC-CME are clinicians and researchers from across the globe, led by a core group of GFTC members. Through education of physicians, nurses, and allied health professionals, ITAC-CME is committed to disseminating relevant and peer-reviewed prophylaxis and treatment guidelines for VTE in cancer that will help to reduce a substantial economic burden on health care systems and improve the lives of millions of patients worldwide.
Скриншоты
Оценки пользователей
Приложение еще не оценено в Малайзия.
История оценок
Int Установки
Last 30 days
Int Доход
Last 30 daysInt Отзывы
Оценки
История позиций в топах
История рейтингов пока не доступна
Позиции в категории
|
Рейтинг
|
Категория
|
Позиция
|
|---|---|---|
|
Топ бесплатных
|
|
240
|
Ключевые слова
Int Конкуренты
| Name | Отзывы | Последнее обновление | |
|---|---|---|---|
Anticoagulation Manager
|
0
|
1 год назад | |
Manuel pratique d’oncologie
Pour internes et praticiens
|
0
|
11 месяцев назад | |
EHRA Key Messages
|
0
|
1 год назад | |
ASH Pocket Guides
|
0
|
6 месяцев назад | |
FROG Oncogériatrie
FRancilian Oncogeriatric Group
|
0
|
1 год назад | |
ASH Pubs | Blood
|
0
|
3 года назад | |
SFMV 2024
Dijon du 25 au 27 09 2024
|
0
|
2 недели назад | |
Riete Registry
|
0
|
1 месяц назад | |
EchoRight
|
0
|
2 года назад | |
IPSS-M Risk Calculator
MDS Prognosis Calculator
|
0
|
1 год назад |
Int Доходы и Загрузки
Получите ценные инсайты о производительности Int с помощью нашей аналитики.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.
Информация о приложении
- Категория
- Medical
- Разработчик
- Rachid Nouar
- Языки
- English, French, Portuguese, Russian, Spanish
- Последнее обновление
- 2.0.1 (1 год назад )
- Выпущено
- Dec 5, 2014 (9 лет назад )
- Также доступно в
- Израиль, Румыния, Гонконг (САР), Канада, Франция, Перу, Пакистан, Новая Зеландия, Норвегия, Нидерланды, Нигерия, Малайзия, Мексика, Ливан, Казахстан, Кувейт, Республика Корея, Филиппины, Индия, Польша, Португалия, Россия, Саудовская Аравия, Швеция, Сингапур, Таиланд, Турция, Тайвань, Украина, Соединенные Штаты, Вьетнам, Южно-Африканская Республика, Дания, Аргентина, Австрия, Австралия, Азербайджан, Бельгия, Бразилия, Беларусь, Швейцария, Чили, Китай, Колумбия, Чехия, Германия, Япония, Доминиканская Республика, Алжир, Эквадор, Египет, Испания, Финляндия, Великобритания, Греция, Венгрия, Индонезия, Ирландия, ОАЭ, Италия
- Обновлено
- 3 недели назад
AppTail.